Ferroptosis: a critical mechanism of N6-methyladenosine modification involved in carcinogenesis and tumor progression

被引:0
|
作者
Qingqing Wei [1 ,2 ,3 ]
Changning Xue [1 ,2 ,3 ]
Mengna Li [1 ,2 ,3 ]
Jianxia Wei [1 ,2 ,3 ]
Lemei Zheng [1 ,2 ,3 ,4 ]
Shipeng Chen [1 ,2 ,3 ]
Yumei Duan [1 ,2 ,3 ]
Hongyu Deng [1 ,2 ,4 ]
Faqing Tang [1 ,2 ,4 ]
Wei Xiong [1 ,2 ,3 ]
Ming Zhou [1 ,2 ,3 ,4 ]
机构
[1] NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University
[2] Cancer Research Institute and School of Basic Medical Sciences, Central South University
[3] The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Central South University
[4] Hunan Key Laboratory of Oncotarget Gene, Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R730 [一般性问题];
学科分类号
100214 ;
摘要
Ferroptosis is an iron-dependent regulatory cell necrosis induced by iron overload and lipid peroxidation. It occurs when multiple redoxactive enzymes are ectopically expressed or show abnormal function. Hence, the precise regulation of ferroptosis-related molecules is mediated across multiple levels, including transcriptional, posttranscriptional, translational, and epigenetic levels. N6-methyladenosine(m6A) is a highly evolutionarily conserved epigenetic modification in mammals. The m6A modification is commonly linked to tumor proliferation, progression, and therapy resistance because it is involved in RNA metabolic processes. Intriguingly, accumulating evidence suggests that dysregulated ferroptosis caused by the m6A modification drives tumor development. In this review, we summarized the roles of m6A regulators in ferroptosis-mediated malignant tumor progression and outlined the m6A regulatory mechanism involved in ferroptosis pathways. We also analyzed the potential value and application strategies of targeting m6A/ferroptosis pathway in the clinical diagnosis and therapy of tumors.
引用
收藏
页码:1119 / 1132
页数:14
相关论文
共 50 条
  • [1] Ferroptosis: a critical mechanism of N6-methyladenosine modification involved in carcinogenesis and tumor progression
    Wei, Qingqing
    Xue, Changning
    Li, Mengna
    Wei, Jianxia
    Zheng, Lemei
    Chen, Shipeng
    Duan, Yumei
    Deng, Hongyu
    Tang, Faqing
    Xiong, Wei
    Zhou, Ming
    SCIENCE CHINA-LIFE SCIENCES, 2024, 67 (06) : 1119 - 1132
  • [2] Autophagy: a critical mechanism of N6-methyladenosine modification involved in tumor progression and therapy resistance
    Wang, Feiyang
    Liao, Qiudi
    Qin, Zihao
    Li, Jingyi
    Wei, Qingqing
    Li, Mengna
    Deng, Hongyu
    Xiong, Wei
    Tan, Ming
    Zhou, Ming
    CELL DEATH & DISEASE, 2024, 15 (10):
  • [3] The crucial roles of N6-methyladenosine (m6A) modification in the carcinogenesis and progression of colorectal cancer
    Zhihao Fang
    Yiqiu Hu
    Jinhui Hu
    Yanqin Huang
    Shu Zheng
    Cheng Guo
    Cell & Bioscience, 11
  • [4] The crucial roles of N6-methyladenosine (m6A) modification in the carcinogenesis and progression of colorectal cancer
    Fang, Zhihao
    Hu, Yiqiu
    Hu, Jinhui
    Huang, Yanqin
    Zheng, Shu
    Guo, Cheng
    CELL AND BIOSCIENCE, 2021, 11 (01):
  • [5] The role of N6-methyladenosine modification in tumor angiogenesis
    Qin, Lifei
    Zeng, Xinya
    Qiu, Xinze
    Chen, Xingmei
    Liu, Shiquan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [6] Mechanism of N6-Methyladenosine Modification in the Pathogenesis of Depression
    Xian, Zhuohang
    Tian, Liangjing
    Yao, Zhixuan
    Cao, Lei
    Jia, Zhilin
    Li, Gangqin
    MOLECULAR NEUROBIOLOGY, 2024, : 5484 - 5500
  • [7] Connecting N6-methyladenosine modification to ferroptosis resistance in hepatoblastoma COMMENT
    Peng, Wan-Xin
    Mo, Yin-Yuan
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (04):
  • [8] Functions of RNA N6-methyladenosine modification in cancer progression
    Chen, Bing
    Li, Ya
    Song, Ruifeng
    Xue, Chen
    Xu, Feng
    MOLECULAR BIOLOGY REPORTS, 2019, 46 (01) : 1383 - 1391
  • [9] Functions of RNA N6-methyladenosine modification in cancer progression
    Bing Chen
    Ya Li
    Ruifeng Song
    Chen Xue
    Feng Xu
    Molecular Biology Reports, 2019, 46 : 2567 - 2575
  • [10] Functions of RNA N6-methyladenosine modification in cancer progression
    Chen, Bing
    Li, Ya
    Song, Ruifeng
    Xue, Chen
    Xu, Feng
    MOLECULAR BIOLOGY REPORTS, 2019, 46 (02) : 2567 - 2575